Vinh Quang Tran
Family · Westminster, CANPI 1790474518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,902, more than ten times the $291 reported in 2023. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$919
- Amgen$632
- Ardelyx, Inc.$599
- Novartis$437
- Boehringer Ingelheim$431
- AstraZeneca$411
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,609100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $919 |
| Amgen | 17 | $632 |
| Ardelyx, Inc. | 25 | $599 |
| Novartis | 22 | $437 |
| Boehringer Ingelheim | 14 | $431 |
| AstraZeneca | 14 | $411 |
| Merck | 21 | $409 |
| Lilly USA, LLC | 16 | $395 |
| Scilex Pharmaceuticals Inc. | 4 | $309 |
| GSK | 11 | $276 |
| Xeris Pharmaceuticals, Inc. | 8 | $269 |
| Gilead | 7 | $262 |
| Aimmune Therapeutics, Inc. | 13 | $235 |
| Novo Nordisk | 10 | $197 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Sanofi | 1 | $112 |
| Dexcom, Inc. | 3 | $64 |
| Vivus LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Shield Therapeutics Inc | 3 | $52 |
| Nestle Healthcare Nutrition Inc. | 3 | $47 |
| Ironwood Pharmaceuticals, Inc | 2 | $44 |
| Optinose US, Inc. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Insulet Corporation | 1 | $30 |
| Pfizer | 1 | $22 |
| Exact Sciences | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Mannkind Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,609 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other family in Westminster
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.